Postprandial blood glucose

There are 68 papers on postprandial blood glucose in aging research: 43 trials and 11 observational studies in people, 6 in animals, 7 reviews.

Biomarker

68 papers study it80 more mention it32 findings

9 new papers in 30 daysSee all 148 papers on postprandial blood glucose

“A correlation between postprandial glycemia and GIFC after 12 weeks was detected (r = 0.37; p = 0.04)”
Pilates Method Training: Functional and Blood Glucose Responses of Older Women With Type 2 DiabetesJournal of strength and conditioning research2018doi:10.1519/jsc.0000000000002704
  • Human trial43
  • Humans11
  • Animals6

Interventions

10

Acarbose

downin humans13downin mice2

15 studies
  1. Acarbose decreases postprandial blood glucose in type 1 diabetes patients, 90 minutes after meal.

    Human trialin type 1 diabetes patients, 90 minutes after mealn = 20

  2. Acarbose decreases postprandial blood glucose in humans (added to diet alone, sulfonylurea, biguanide or insulin).

    Human trialadded to diet alone, sulfonylurea, biguanide or insulin1 year

  3. Acarbose decreases postprandial blood glucose in patients with non-insulin-dependent diabetes mellitus (approximately 56 mg/dL reduction vs 13 mg/dL with placebo).

    Human trialin patients with non-insulin-dependent diabetes mellitus200 mg TID24 weeks

  4. Acarbose decreases postprandial blood glucose in humans (added to sulfonylureas in type 2 diabetes; compared with placebo).

    Human trialadded to sulfonylureas in type 2 diabetes; compared with placebothree monthsn = 14

  5. Acarbose decreases postprandial blood glucose in humans.

    Human trialType 1 diabetes; intensified insulin therapy; abandonment of the 30-minute injection-eating interval; compared with pretreatment while observing the interval100 mg three times daily3 daysn = 7

  6. Acarbose decreases postprandial blood glucose in humans (co-treated with sulfonylureas).

    Human trialco-treated with sulfonylureas100 mg tablets100 mg tid12 weeks

  7. Acarbose decreases postprandial blood glucose in humans (compared with baseline values).

    Human trialcompared with baseline values4 monthsn = 15

  8. Acarbose decreases postprandial blood glucose in humans with fixed 75 g sucrose load (161, 145, 120 and 102 mg/dl at 0, 50, 100 and 200 mg acarbose).

    Human trialwith fixed 75 g sucrose load0, 50, 100 and 200 mg acarbosen = 4

  9. Acarbose decreases postprandial blood glucose in humans (healthy subjects receiving fiber-free formula diets) (Postprandial glucose AUC: 1.836 to -504 mg/dl X min in Study 1; 587 to -302 mg/dl X min in Study 2).

    Human trialhealthy subjects receiving fiber-free formula diets10 to 14 days

  10. Acarbose decreases postprandial blood glucose in humans (added to glibenclamide 15 mg/day).

    Human trialadded to glibenclamide 15 mg/day3 X 100 mg dailythree weeksn = 9

All 15

More on Acarbose

Chenopodium quinoa

downin humans1

1 study
  1. Chenopodium quinoa decreases postprandial blood glucose in humans (4.57 ± 2.7 mmol/L vs 2.2 ± 2.8 mmol/L).

    Human trial14 weeksn = 60

  2. Chenopodium quinoa decreases postprandial blood glucose in humans (early-stage T2DM) (4.57 ± 2.7 mmol/L vs 2.2 ± 2.8 mmol/L, P <0.001).

    Human trialearly-stage T2DMn = 60

More on Chenopodium quinoa

Fractionated soy-casein composite peptides

downin humans1downin mice1

1 study
  1. Fractionated soy-casein composite peptides decrease postprandial blood glucose in humans (postprandial).

    Human trialpostprandialfractionated soy-casein composite peptides

  2. Fractionated soy-casein composite peptides decrease postprandial blood glucose in mice (postprandial).

    Animalspostprandialfractionated soy-casein composite peptides

More on Fractionated soy-casein composite peptides

Exercise

downin humans1

1 study
  1. Exercise decreases postprandial blood glucose in humans (type 2 diabetes mellitus; compared with control) (Hedges' g = -1.82; SE = 0.23; P < 0.05).

    Reviewtype 2 diabetes mellitus; compared with control

More on Exercise

Dapagliflozin + glimepiride + metformin

downin humans1

1 study
  1. Dapagliflozin + glimepiride + metformin is linked with lower postprandial blood glucose in humans (-71.11±1.24 mg/dL).

    Humans12±2 weeksn = 3,770

More on Dapagliflozin + glimepiride + metformin

Auricular acupressure

downin humans1

1 study
  1. Auricular acupressure decreases postprandial blood glucose in humans.

    Human trial8 weeksn = 42

More on Auricular acupressure

Pilates

downin humans1

1 study
  1. Pilates decrease postprandial blood glucose in humans (older women with type 2 diabetes) (246.1 ± 58.5 vs. 207.6 ± 49.1 mg·dl at 12 weeks).

    Human trialolder women with type 2 diabetes60 minutes, 3 times per week12 weeksfemales

More on Pilates

Baicalein + acarbose

downin mice1

1 study
  1. Baicalein + acarbose decreases postprandial blood glucose in mice (combined treatment after sucrose loading) (synergistic; comparable to 8 mg/kg acarbose).

    Animalscombined treatment after sucrose loading80 mg/kg baicalein and 1 mg/kg acarbose

More on Baicalein + acarbose

Baicalein

downin mice1

1 study
  1. Baicalein decreases postprandial blood glucose in mice after sucrose loading; dose-dependent.

    Animalsafter sucrose loading; dose-dependent

More on Baicalein

Magnesium hydroxide and aluminum hydroxide

no changein humans1

1 study
  1. Magnesium hydroxide and aluminum hydroxide showed no clear effect on postprandial blood glucose in humans (co-administered with acarbose, after a 75 g sucrose load).

    Human trialco-administered with acarbose, after a 75 g sucrose loadsuspensionblood10 ml4 daysmalesn = 24

More on Magnesium hydroxide and aluminum hydroxide

Associations

6

Binge drinking

upin humans1

1 study
  1. Binge drinking is associated with postprandial blood glucose in humans (Resistance-trained binge drinkers versus resistance-trained low alcohol consumers) (RTB 137.58±21.54 mg/dL versus RTL 103.83±19.82 mg/dL).

    HumansResistance-trained binge drinkers versus resistance-trained low alcohol consumersfemales

More on Binge drinking

Hunger

upin humans1

1 study
  1. Hunger is associated with postprandial blood glucose in humans.

    Humans

Eating companions

downin humans1

1 study
  1. Eating companions are associated with postprandial blood glucose in humans (than eating alone).

    Humansthan eating alone

More on Eating companions

Cardiovascular disease

upin humans1

1 study
  1. Postprandial blood glucose is associated with cardiovascular disease in humans.

    Review

More on Cardiovascular disease

Diabetes mellitus

upin humans1

1 study
  1. Postprandial blood glucose is associated with diabetes mellitus in humans.

    Review

More on Diabetes mellitus

Functional capacity

upin humans1

1 study
  1. Postprandial blood glucose is associated with functional capacity in humans (older women with type 2 diabetes) (r = 0.37).

    Human trialolder women with type 2 diabetes12 weeksfemales

Latest

Dec 2025: 1Jan 2026: 4Feb 2026: 9Mar 2026: 4Apr 2026: 1May 2026: 0Jun 2026: 2Jul 2026: 1Aug 2026: 1Sep 2026: 1Oct 2026: 4Nov 2026: 634 papers in 12 months

See all 148 papers on postprandial blood glucose